Company Overview of Vasogen Inc.
As of October 22, 2009, Vasogen Inc. was acquired by IntelliPharmaCeutics Ltd., in a reverse merger transaction. Vasogen Inc. focuses on the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neuro-inflammatory disorders. It is not advancing the development of its products and is focused is on exploring strategic options that may include a sale of the company, a merger, an acquisition, or other strategic alternative. The company was founded 1980 and is headquartered in Mississauga, Canada.
4 Robert Speck Parkway
Mississauga, ON L4Z 1S1
Founded in 1980
Key Executives for Vasogen Inc.
Vasogen Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|2007262 Ontario, Inc.||Americas|
|2056273 Ontario, Inc.||Americas|
|AB BioPharma Inc.||Americas|
|AbCelex Technologies Inc.||Americas|
|AbCellera Biologics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vasogen Inc., please visit www.vasogen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.